Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Fig. FACS analysis of CD40 Ligand on HEK293/Human CD40 Ligand Stable Cell Line.
FACS assay shows that CD40 Ligand Antibody can bind to HEK293/Human CD40 Ligand Stable Cell Line. HEK293/Human CD40 Ligand Stable Cell Line was red line, Negative control HEK293 cells was grey line(QC tested).
Loaded Human CD40, Fc Tag (Cat. No. CD0-H5253) on Protein A Biosensor, can bind Human CD40 Ligand, His,Flag Tag, premium grade (Cat. No. CDL-H52Db) with an affinity constant of 1.58 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Dapirolizumab pegol | Anti-CD40L-Fab; Anti-CD40L-Fab-PEG; CDP-7657; CD40L - Fab; BIIB-133 | Phase 3 Clinical | Biogen Inc, Ucb | Autoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Lupus Erythematosus, Systemic; Skin and Connective Tissue Diseases | Details |
Dazodalibep | VIB-4920; MEDI-4920; HZN-4920(Horizon Therapeutics); UNII-HN5US76BWF; WHO-11399 | Phase 3 Clinical | Medimmune Llc, Horizon Therapeutics PLC | Rejection of renal transplantation; Sjogren's Syndrome; Arthritis, Rheumatoid; Rejection of organ transplantation; Lupus Nephritis; Sjogren-Larsson Syndrome | Details |
Frexalimab | INX-021; SAR-441344 | Phase 3 Clinical | Immunext Inc | Diabetes Mellitus, Type 1; Sjogren's Syndrome; Multiple Sclerosis; Lupus Erythematosus, Systemic; Sjogren-Larsson Syndrome | Details |
Anti-CD40L antibody (Bristol-Myers Squibb) | Phase 2 Clinical | Bristol-Myers Squibb Company | Immunologic Deficiency Syndromes | Details | |
AdCD40L | Phase 2 Clinical | Uppsala University | Urinary Bladder Neoplasms; Melanoma | Details | |
Tegoprubart | AT-1501 | Phase 2 Clinical | Als Therapy Development Institute | Diabetes Mellitus, Type 1; Rejection of renal transplantation; Glomerulonephritis, IGA; Diabetes Mellitus; Amyotrophic Lateral Sclerosis | Details |
Delolimogene mupadenorepvec | LOAd-703 | Phase 2 Clinical | Uppsala University, Lokon Pharma | Biliary Tract Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Melanoma | Details |
CD40 ligand expressing MSLN-CAR T cells | Phase 2 Clinical | Pla General Hospital | Solid tumours | Details | |
CD40L-augmented Tumor Infiltrating Lymphocytes (H Lee Moffitt Cancer Center & Research Institute) | Phase 2 Clinical | H Lee Moffitt Cancer Center & Research Institute | Carcinoma, Non-Small-Cell Lung | Details | |
Letolizumab | BMS-986004; BMS2h-572-633-CT-L2 | Phase 1 Clinical | Bristol-Myers Squibb Company | Purpura, Thrombocytopenic, Idiopathic; Graft vs Host Disease | Details |
TNX-1500 | TNX-1500 | Phase 1 Clinical | Tonix Pharmaceuticals Holding Corp | Autoimmune Diseases; Rejection of organ transplantation; Autoimmune Diseases of the Nervous System | Details |
MEM-288 | MEM-288 | Phase 1 Clinical | Memgen | Solid tumours; Head and Neck Neoplasms; Carcinoma, Merkel Cell; Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma | Details |
IBI355 | IBI-355 | Phase 1 Clinical | Innovent Biologics(Suzhou) Co Ltd | Sjogren's Syndrome; Lupus Erythematosus, Systemic | Details |
APB-A1 | APB-A1; Lu-AG22515 | Phase 1 Clinical | AprilBio Co Ltd | Neuromyelitis Optica | Details |
Dapirolizumab pegol | Anti-CD40L-Fab; Anti-CD40L-Fab-PEG; CDP-7657; CD40L - Fab; BIIB-133 | Phase 3 Clinical | Biogen Inc, Ucb | Autoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Lupus Erythematosus, Systemic; Skin and Connective Tissue Diseases | Details |
Dazodalibep | VIB-4920; MEDI-4920; HZN-4920(Horizon Therapeutics); UNII-HN5US76BWF; WHO-11399 | Phase 3 Clinical | Medimmune Llc, Horizon Therapeutics PLC | Rejection of renal transplantation; Sjogren's Syndrome; Arthritis, Rheumatoid; Rejection of organ transplantation; Lupus Nephritis; Sjogren-Larsson Syndrome | Details |
Frexalimab | INX-021; SAR-441344 | Phase 3 Clinical | Immunext Inc | Diabetes Mellitus, Type 1; Sjogren's Syndrome; Multiple Sclerosis; Lupus Erythematosus, Systemic; Sjogren-Larsson Syndrome | Details |
Anti-CD40L antibody (Bristol-Myers Squibb) | Phase 2 Clinical | Bristol-Myers Squibb Company | Immunologic Deficiency Syndromes | Details | |
AdCD40L | Phase 2 Clinical | Uppsala University | Urinary Bladder Neoplasms; Melanoma | Details | |
Tegoprubart | AT-1501 | Phase 2 Clinical | Als Therapy Development Institute | Diabetes Mellitus, Type 1; Rejection of renal transplantation; Glomerulonephritis, IGA; Diabetes Mellitus; Amyotrophic Lateral Sclerosis | Details |
Delolimogene mupadenorepvec | LOAd-703 | Phase 2 Clinical | Uppsala University, Lokon Pharma | Biliary Tract Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Melanoma | Details |
CD40 ligand expressing MSLN-CAR T cells | Phase 2 Clinical | Pla General Hospital | Solid tumours | Details | |
CD40L-augmented Tumor Infiltrating Lymphocytes (H Lee Moffitt Cancer Center & Research Institute) | Phase 2 Clinical | H Lee Moffitt Cancer Center & Research Institute | Carcinoma, Non-Small-Cell Lung | Details | |
Letolizumab | BMS-986004; BMS2h-572-633-CT-L2 | Phase 1 Clinical | Bristol-Myers Squibb Company | Purpura, Thrombocytopenic, Idiopathic; Graft vs Host Disease | Details |
TNX-1500 | TNX-1500 | Phase 1 Clinical | Tonix Pharmaceuticals Holding Corp | Autoimmune Diseases; Rejection of organ transplantation; Autoimmune Diseases of the Nervous System | Details |
MEM-288 | MEM-288 | Phase 1 Clinical | Memgen | Solid tumours; Head and Neck Neoplasms; Carcinoma, Merkel Cell; Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma | Details |
IBI355 | IBI-355 | Phase 1 Clinical | Innovent Biologics(Suzhou) Co Ltd | Sjogren's Syndrome; Lupus Erythematosus, Systemic | Details |
APB-A1 | APB-A1; Lu-AG22515 | Phase 1 Clinical | AprilBio Co Ltd | Neuromyelitis Optica | Details |
This web search service is supported by Google Inc.